KartikV.ShenoyMD
Pulmonology • Philadelphia, PAAsthma & COPD, Critical Care Medicine, Lung Transplantation Medicine, Pleural Disease
Associate Professor. Thoracic Medicine and Surgery. Temple Lung Center
Dr. Shenoy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 N Broad St
Philadelphia, PA 19140Phone+1 215-707-5864Fax+1 215-707-6867
Summary
- Dr. Kartik Shenoy is a pulmonologist in Philadelphia, PA and is affiliated with Temple University Hospital. He received his medical degree from Northeast Ohio Medical University and has been in practice 12 years. He specializes in asthma & copd, critical care medicine, lung transplantation medicine, and pleural disease and is experienced in asthma, chronic obstructive pulmonary disease, transplant pulmonology, interstitial lung disease, and critical care medicine.
Education & Training
Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011- Temple University HospitalResidency, Internal Medicine, 2005 - 2008
Northeast Ohio Medical UniversityClass of 2005
Certifications & Licensure
PA State Medical License 2008 - 2024
NJ State Medical License 2019 - 2021- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) Start of enrollment: 2010 Nov 01
- Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy Start of enrollment: 2014 Apr 28
- A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA Start of enrollment: 2014 Nov 19
Publications & Presentations
PubMed
- 8 citationsEmphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.Vickram Tejwani, Ashraf Fawzy, Nirupama Putcha, Peter J. Castaldi, Michael H. Cho
Chest. 2021-10-01 - 41 citationsRace and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction.A. James Mamary, Jeffery I Stewart, Gregory L. Kinney, John E. Hokanson, Kartik Shenoy
Chronic Obstructive Pulmonary Diseases. 2018-07-02 - 12 citationsPulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study.Carrie L. Pistenmaa, P. Nardelli, Samuel Y. Ash, Carolyn E. Come, A.A. Diaz
Chest. 2021-08-01
Press Mentions
Using Innovative Research to Drive New Opportunities for Lung TreatmentsFebruary 1st, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
